Jul 7, 2017 articles Machine Learning and the march towards precision medicine Taking a closer look at how big data and machine learning is transforming precision medicine, Adi Gaskell covers our work at BenevolentAI and the partnership with Sheffield Institute for Translational Neuroscience (SITraN) for Motor Neuron Disease research. DRUG DISCOVERY , ARTIFICIAL INTELLIGENCE , MACHINE LEARNING , PRECISION MEDICINE
Jun 15, 2017 articles BenevolentAI: drug research startup goes on hiring spree as UK’s artificial intelligence sector booms Our founder Ken Mulvany features in an article looking at the UK’s growing performance in AI technology and the investment the country’s industry is attracting. Ken speaks to Bloomberg’s Giles Turner about BenevolentAI's hiring spree and the 50 roles we are looking to fill. DRUG DISCOVERY , ARTIFICIAL INTELLIGENCE , KEN MULVANY
Apr 26, 2017 articles 9 Computational Drug Discovery Startups Using AI Nanalyze includes BenevolentAI in its round up of computational drug discovery start-ups using AI. DRUG DISCOVERY , ARTIFICIAL INTELLIGENCE , BENEVOLENTAI
Apr 25, 2017 articles A British tech unicorn is trying to cure Alzheimer's and ALS with artificial intelligence Ken Mulvany, is interviewed by Business Insider UK in an article exploring BenevolentAI’s work to develop new drugs for diseases like Alzheimer’s and ALS. ARTIFICIAL INTELLIGENCE , DRUG DISCOVERY , ALZHEIMER'S , KEN MULVANY , ALS
